Abbott Laboratories said Wednesday it beat profit expectations in the third quarter, with net income from continuing operations climbing to $873 million, or 55 cents a share. Revenue for the quarter was $5.37 billion, up 2 percent from $5.26 billion in the same period a year ago, but short of the $5